Delivery Order SPE2DB22D3501-SPE2DB25FWQ96
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,626.99 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 88 mcg tablets in quantities of 1,000 units. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, operates under a firm fixed-price structure with no set-aside designation. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,224.85 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 75 MCG Capsule in quantities of 30 units. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price pricing and does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,555.90 firm fixed-price contract is for the delivery of 4,563,268 units of the prescription drug Levothyroxine 175 mcg capsules. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at two hundred eleven dollars and seventy-two cents to Amerisourcebergen Drug Corporation for the supply of fifty microgram levothyroxine capsules. Under the terms of the order, Amerisourcebergen will deliver thirty capsules of the pharmaceutical to a facility in Conshohocken, Pennsylvania, with performance required between June twenty-sixth and June twenty-seventh of twenty twenty-three. As a major provider of medical...
- The federal contract award is for the delivery of 4,568,494,683 vials of Levothyroxine 500 mcg to the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price of $2,938.11 and an Ultimate Completion Date of June 10, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This delivery order is part of a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,806,709 vials of levothyroxine 200 mcg, a thyroid medication, with a ceiling value of $1,422.01. The contract has an ultimate completion date of April 7, 2025 and was awarded on April 4, 2025. It is a firm fixed price contract with no set-aside designation, indicating open...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $97,000 to Amerisourcebergen Drug Corporation for the supply of 1,000 boxes of 88 mcg Levothyroxine sodium tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency requirements. No set aside designation or subcontractors were identified. The delivery order was issued under an existing DLA pharmaceutical...
- This federal contract award, valued at $5,677.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Levothyroxine 500 MCG vials, a critical pharmaceutical product. This is a firm fixed-price Delivery Order contract with a completion date of February 5, 2024. The contract was awarded on February 2, 2024 and does not have a set-aside designation, indicating open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 micrograms on August 15, 2025, with a ceiling value of $1,430.59 and an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWQ96Delivery Order
The Defense Logistics Agency awarded a $5,609.93 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Levothyroxine 100 MCG vials, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies supporting military healthcare programs worldwide. Levothyroxine, a critical synthetic thyroid hormone medication, supports the medical needs of the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's extensive federal pharmaceutical distribution portfolio and demonstrated capability to compete successfully in open procurement processes have established the company as a key vendor for military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/30/25 |